Parliament Workbench
Data: Official Report to 19 Nov 2026

Official Report · Committee

Continued Petitions

Surgical Mesh and Fixation Devices (PE1865)

Wednesday 8 June 2022 Citizen Participation and Public Petitions Committee About 09:30–10:30 Petitions 58 contributions · 7 speakers

Speakers

Choose an MSP to read only their contributions

The record

58 contributions
Jackson Carlaw Con The Convener · Eastwood
link

Good morning. I welcome everyone to the 10th meeting in 2022 of the Citizen Participation and Public Petitions Committee.

We have a number of interesting evidence sessions this morning, the first of which is on continued petition PE1865. It seems that the committee has been preoccupied with that petition for coming up to a decade. It almost feels like 10 meetings and 10 years of this important issue.

The petition, which was lodged by Roseanna Clarkin and Lauren McDougall, calls on the Scottish Parliament to urge the Scottish Government to suspend the use of all surgical mesh and fixation devices while a review of all surgical procedures that use polyester, polypropylene or titanium is carried out, and while guidelines for the surgical use of mesh are established.

We have previously met the Minister for Public Health, Women’s Health and Sport, Maree Todd. I welcome her again and thank her for attending. We are also delighted to have with us the chief medical officer, Professor Sir Gregor Smith. Terry O’Kelly is back with us, but online. I say good morning to him as well.

We previously considered the petition in an online meeting in which we took evidence from Dr Fernando Spencer Netto of Shouldice hospital in Canada. A number of questions arise from all the evidence that we have heard.

As we have gone along, we have had a lot of evidence that many people have benefited from mesh as a treatment for hernias. However, I will start with a couple of back questions, as this might be the last time that we cover mesh in quite such wide detail.

In relation to the Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Act 2022, there have been some reports that we are still trying to negotiate—

Maree Todd SNP The Minister for Public Health, Women’s Health and Sport · Caithness, Sutherland and Ross
link

Convener, I have an opening statement, if you would like to hear it.

Maree Todd SNP Caithness, Sutherland and Ross
link

It might set the context and answer some of the questions that you are keen to put to me.

Maree Todd SNP Caithness, Sutherland and Ross
link

Thank you for inviting me and giving me the opportunity to return to this important topic.

I am pleased to say that we have made significant progress in our action on transvaginal mesh. We have established a national service for the management of mesh complications, and women have options with regard to their treatment, which can be undertaken in Scotland or elsewhere in the United Kingdom and with an independent provider if desired.

Most recently, the Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Act 2022 was introduced, and the associated scheme opened on 6 June—just this Monday. The contract with Spire Healthcare has been concluded, and arrangements are being made for the first patients to attend for surgery. Meanwhile, discussions with Dr Veronikis are progressing.

I am mindful of the concerns that have been raised by campaigners over the years about the use of mesh in other sites, such as in hernia repair. That is what I will focus on. I am sorry to hear of any instance of complications and the adverse effect that they have had on individual patients and their wider families.

As members know, the Scottish Health Technologies Group has looked into the use of mesh in hernia repair and published two reports on the subject, one of which was published shortly after my previous committee appearance. Those reports, which are based on current published evidence, support the continued use of mesh in a variety of abdominal wall and groin herniae. That is, of course, subject to all the tenets of realistic medicine: ensuring shared decision making and informed consent with knowledge of the benefits, risks, alternative measures and the possibility of doing nothing.

We have discussed the findings of those reports with professional bodies, including the royal colleges and the British Hernia Society, and we will continue to work with them on that important issue. Work is also going on to establish the medical device information system—MDIS—which will provide important surveillance and outcome information.

Since I last appeared before the committee, the chief medical officer has—in December 2021—written to board chief executives and medical directors to draw their attention to the SHTG report. In the letter, the CMO asked health boards to consider the availability of non-mesh surgery, how best to address skill gaps, if they exist, and the development of broader clinical networks for the management of complex cases. The actions resulting from that will be discussed at a meeting of the Scottish Association of Medical Directors in August.

I know that the committee has received a report from Shouldice hospital in Canada. Although the results reported are notable, it is important to remember that Shouldice hospital is a specialist centre dedicated to natural tissue repair and that it operates in a healthcare system that is very different from the national health service in Scotland. For that reason, the report should not be considered in isolation; rather, it needs to be considered in the context of the wider available evidence.

As I have said before in front of the committee, there are, of course, still some gynaecology procedures for which the use of mesh has not been halted. In those circumstances, there is a high vigilance protocol in place across NHS Scotland. It is important to remember that some of those procedures are complex and long established with few, if any, viable alternatives. Therefore, to suspend the use of mesh would leave a cohort of people with limited or no treatment options.

I reassure committee members, as well as the campaigners who lodged the petition, that the Government is absolutely committed to ensuring that everyone with mesh complications gets the care and treatment that they need.

I look forward to answering any questions that members have on the matter.

Jackson Carlaw Con The Convener · Eastwood
link

Thank you, minister. That is very helpful.

The evidence that we have heard on the second area of mesh concern supports the view that there are nuances that mean that the way in which we might progress in future is different from the prognosis in relation to the transvaginal mesh campaign.

You mentioned the continuing conversations with Dr Veronikis. “Negotiations continue” has been the situation for as long as I can recall—in fact, I might even have been a list MSP when we first heard that said. I recognise that there is a commercial interest in the Missouri facility that Dr Veronikis operates, and I know that, at times, the conversations have been strained. However, inherent in the 2022 act is a belief that the facility would be one of the identified options and that something would be concluded with it. Therefore, naturally enough, expectations are raised that something will be forthcoming that can assist women in the near future. Some people will have thought that it would be even sooner than now. Is it difficult to say where we are in those negotiations and how they are proceeding?

Maree Todd SNP Caithness, Sutherland and Ross
link

No. I have to commend NHS National Services Scotland, which is pursuing the conclusion of that contract. It is very close to finalising that. I know that it is frustrating but, if we stop and reflect on the differences in the medical and legal systems in the two countries, we see that it is understandable that there has been a deal of to-ing and fro-ing. However, I am confident that everything is being done to conclude that contract, and I hope to be able to update Parliament on it soon.

Jackson Carlaw Con The Convener · Eastwood
link

Thank you, minister. I have one further follow-up question.

We have discussed the nuances in relation to hernia mesh. At times, it seems that the issue has been the need for a proper explanation of options to patients. That is one of the aspects that Professor Alison Britton is looking at in her casework review with regard to the way in which women progressing through the transvaginal hernia mesh issue have been treated. Her inquiry has been going on for some time; a month or so ago, I asked a question about it in Parliament. I wonder whether you are able to offer any update on where we are with the review, as some of what Professor Britton may report might be of interest with regard to the need for patients to be properly notified and made aware of the options that are available to them.

Maree Todd SNP Caithness, Sutherland and Ross
link

Absolutely. The review is now well under way. It was established following the serious concerns that were raised by some of the women about whether their case records accurately reflected the treatment that they had received. It is expected to conclude later this year.

In Scotland, we have a system that is based on realistic medicine—I am sure that Professor Sir Gregor Smith will want to come in on this. We want all patients, at all times, to be well informed and to be part of the decision-making process. We use the acronym BRAN to remind everybody who is involved to consider the benefits, risks and alternatives, whether the intervention is needed now, and what will happen if we do nothing. That type of conversation is vitally important when people are considering surgery.

There is no risk-free option when someone has a hernia, and it is important that people are well able to ask questions about, and understand, the proposed treatment—not just the risks in general, but how those risks apply to them—in order to make a fully informed decision on how they want to proceed.

I will let Gregor Smith say more on that.

Professor Sir Gregor Smith Scottish Government
link

Shared decision making is at the heart of the relationship between people who receive care and those who provide it. With regard to realistic medicine, when we began to have a conversation with the profession in late 2015, we saw that there was a need to promote a better approach to shared decision making. Personalised care has been right at the heart of realistic medicine, as we try to create a much more equal relationship between patients and providers of care.

Since that point in time, the shared decision-making approach has—I would say—been whole-heartedly embraced by the profession. It has been supported very much through the work that we have participated in with the General Medical Council on refreshing the ethical and legal obligations around consent. In addition, it has also been greatly supported by our education establishments at the undergraduate and postgraduate levels, through NHS Education for Scotland, with several modules that promote the essence of shared decision making.

The four questions that the minister outlined, which are known by the acronym BRAN—the benefits, risks and alternatives, and what would happen if we did nothing—are now at the heart of consultations. We have them as part of the NHS Near Me electronic platform, which has been used extensively over the past two years and has now increased its presence across the country. They are also part of the letters that we send to out-patients. In those letters, we encourage patients to engage with the clinical team and to use the BRAN questions to ensure that they explore those concepts, so that, when they arrive at a decision, it is well informed and underpinned by consent that can be said to be informed. We know that, if that conversation has happened fully, it is associated with much lower levels of treatment regret afterwards.

Jackson Carlaw Con The Convener · Eastwood
link

I think that the evolution of that exchange and how shared decision making has materially progressed are great. Such a process was historically meant to be in place, but we discovered, in exploring the transvaginal mesh issue, that it was not really in place. If that change has happened, it is a very positive development.

I should say, Mr O’Kelly, that we have a very good video feed for you, so if at any time you feel that you would like to say something, you can just raise a hand and I will know immediately that you are trying to come in. You should not feel that you have to do anything more—I can see you well.

09:45

Minister, on the last occasion we met, you said that it would be very difficult to quantify the extent to which there was a valid underpinning for the petitioners’ concerns, because there was no basis for evidence gathering that would allow for a material judgment to be made about the extent to which any experience was real. Has any thought been given to undertaking some sort of limited sampling or anything like that, just to get an understanding of how many people may be experiencing genuine post-hernia mesh complications?

Maree Todd SNP Caithness, Sutherland and Ross
link

I am not sure that I entirely understand your question, convener. Do you mean a sampling of records or of data? There is a recognition that, where medical devices in particular are used, they need to be more traceable. More clarity is needed on which devices were used where, and we need a system of retrieval in place. We are working closely with the United Kingdom Government on that aspect, so that, in future—I guess this answers your question, as we found ourselves in a situation in which it was quite difficult for us to tell precisely what had happened—that data should be gathered much more routinely. Where there are issues with a product, it should be perfectly straightforward to find out where that product has been used, and there should be a strong audit trail in a patient’s notes.

Alexander Stewart Con Mid Scotland and Fife
link

Minister, you talked about the risks and the benefits, but, in all this, the word “complications” seems to be the problem. Many individuals have given us their testimony that they took the information that they received in good faith and went through the process but then, three, four or five years on, their situation became so difficult that they ended up with a real problem. You talked about consent in the process, but communication is an issue. I believe that anyone who goes in and gets medical support and advice will take it on board, but they may not realise what complications could occur perhaps three, four or five years later, and the damage that could be done.

We have seen the same thing with the hernia situation. People believed, in good faith, that having the mesh put in was the right thing to do because that is what they were advised to do at the time, but it ended up not being the right thing, and that has put them in a really difficult and dangerous situation.

It would be good to get clarity as to how that aspect is communicated, in order to ensure that individuals make the right choices and are not steamrollered by a doctor or clinician who says, “We believe that this is the best treatment for you.” People take such advice in good faith, but, years later, as I said, they may find that that treatment should not have happened.

Maree Todd SNP Caithness, Sutherland and Ross
link

I see that Mr O’Kelly is raising his hand—I am sure that he is very keen to contribute, as a practising surgeon who has to go through such issues with patients time and time again, day in and day out.

You are absolutely on the button, Mr Stewart—it is really important that these decisions are shared, and that is what we are talking about with regard to realistic medicine. We are moving away from what has happened in the past, when we had a paternalistic style of medicine. Back then, the doctor was all-powerful and told the patient what to do, and their advice was almost always taken as law. We now recognise that health is much better when it is delivered in a shared way. People are much more likely to attain good health if the decision making is shared.

The individual has to be party to a decision, and they must be able to discuss it with their clinician. As I said, that discussion should cover not just the general risks, but how those risks apply to that person as an individual. It should be a very individual discussion, and a patient should feel that, instead of having to access the internet in order to find and assess the data themselves, they can, as they make their decision, talk to their own health professional and have the risks explained as those risks apply to them specifically.

Patients are often in a very difficult situation in which there is no risk-free option. If someone has a hernia, continuing to live with it is not a comfortable situation for them to be in, but the options for treating it are never going to be risk free. As you said, an honest, transparent and well-documented discussion about those risks is a very important part of the process.

Secondly, you raised the point that there is sometimes a sense that people are not listened to. As a politician, I—and we all, as politicians—probably hear about that more than it actually happens, through a select few, or even many, stories. We hear from people who have been to see their health professional and have felt that their concerns have been dismissed or their health problems minimised. Again, we are working hard to improve that situation so that people, when they present to a healthcare professional—often, five years on, it will not be the same surgeon who operated on them—will receive a response that is more empathetic and understanding. We want to ensure that they are suitably directed to people who might be able to help them to disentangle whether what they are experiencing is related to the surgery that they have had.

I am sure that Mr O’Kelly will want to come in at this point.

Jackson Carlaw Con The Convener · Eastwood
link

Yes—I think that Mr O’Kelly would like to contribute.

Good morning, Mr O’Kelly—over to you.

Terry O’Kelly Scottish Government
link

Good morning to you, convener, and to the committee. I may well have raised my hand too early. It involves a very good explanation of—Inaudible.

The issue of complications is difficult. In explaining complications, we do not want to flood patients with data and cause anguish or a feeling that something dreadful is inevitably going to happen, given all the things that can happen. Within that, we need to try to allay their fears. Although the risks are relatively small in that they may affect less than 5 per cent or 2 per cent of people, for the person whom the complication affects it is not a negative concept. In that case, there is not a risk of less than 1 per cent—it is a 100 per cent risk, because it has happened to them. There is a notion of the importance of trying to ensure that patients understand the nature of the risk to which they are exposing themselves.

We know, from the work that has gone on around realistic medicine, that health literacy in Scotland is by no means ideal. There is a need, therefore, for clinicians to spend time with patients to ensure not only that they have given them the information, but that it has been assimilated and truly understood. In that respect, it is always a good idea to check and to ask patients to attend with a supporter or advocate if required, particularly when one is engaging in a more invasive and perhaps more risky procedure. That is very important—it is probably the crucial point.

Another important point to consider takes me back to the comments from Donald Rumsfeld, which members may remember. There are the knowns—we know the complications and we have looked at them—and there are the known unknowns: we cannot tell people about what is going to happen in 10 years, because the products have not been available for that period of time and we do not know what the outcome is going to be, so there is a risk there.

However, as Donald Rumsfeld said, there are also the unknown unknowns, and those are the ones that always catch us out. I am not suggesting at all that my colleagues have, in the past, always dressed themselves in glory, but we now need to recognise that we have to be absolutely honest with patients. We need to say that we do not know what is going to happen in 10 years’ time, because a particular device, product or drug has not been available for that length of time, so it is impossible for us to know. We have to tell the patient that, nevertheless, we recognise that, at that moment, given our experience of the timeframes, something will be of benefit to them. We can say to them, “These are the reasons and the risks that we know of, these are the alternatives, and this is what might happen if we do nothing.”

There is quite a lot there—for the patient who is sitting in a doctor’s surgery, that is quite a lot to take on board. However, as Gregor Smith said, an important aspect is not only the questions, but flattening the hierarchy. We need to have the right attitude and give the patient the right environment, which is one in which they feel able to speak up and ask questions.

Alexander Stewart Con Mid Scotland and Fife
link

Following on from the comments from both the minister and Mr O’Kelly, do we have some understanding of mesh itself? Different types of mesh may well undergo different processes. How have we been investigating and taking steps to analyse some of the mesh products themselves, to look at what defects they might have?

Has the Government, or have clinicians themselves, had a look at any of the history to find out whether there are defects that occur with specific types of mesh products, which might be more susceptible or more problematic for individuals? If we are aware that certain products might be more susceptible than others, that might reassure people in the future that the mesh that is being put in will be better, because it is not of a type that has a track record of causing issues in the past.

Minister, perhaps you can answer first.

Maree Todd SNP Caithness, Sutherland and Ross
link

I will let Mr O’Kelly answer the bulk of that question. He can certainly give you a picture of what clinicians are doing to understand those issues. As with medicines, it is possible to do randomised controlled trials with these medical devices in order to learn more about them. It is also possible, as the unit in Canada has done, to collect anecdotal and observational evidence. That happens on an on-going basis in this area of medicine as in any other.

I go back to your concern about how we find out about different types of mesh and which types may have defects. The Cumberlege report focused on the regulation of medical devices, and it found the UK environment wanting in that regard. As a Government, we are absolutely committed to taking forward the recommendations that were made by Baroness Cumberlege and her team, and we have made significant progress on them since the report was published, last year.

Alexander Stewart Con Mid Scotland and Fife
link

Mr O’Kelly, do you want to answer some of that question?

Terry O’Kelly Scottish Government
link

The base material, polypropylene, has been used in surgery for 80 years—I think that it was introduced at the time of the second world war, or perhaps just afterwards. It has been found to be very safe and effective, and it is well tolerated by patients. In vascular surgery, in particular, it is the product of choice. We have learned over time that there have been no major safety issues raised with its use as a suture material.

Mesh itself has evolved over time. The Medicines and Healthcare products Regulatory Agency has looked at hernia mesh. I know that there have been issues with MHRA representatives sitting in front of this committee, but the mesh has been scrutinised very carefully, as the committee will appreciate, both in this country and by similar organisations abroad, such as the Food and Drug Administration in the States. It is recognised that mesh is an implanted product, and it is important that patients understand that, but there does not seem to be an intrinsic issue with the product itself. There are some reports in the press and the published literature of patients having some reactions, but those are very rare.

Given the number of meshes that are used each year and the period of time for which they have been used, going back to the late 1980s, we see very few patients—or, rather, a very low percentage of patients—coming back. As these procedures are common, even rates of less than 1 per cent will mean that a number of patients will appear to have problems related to their surgery. Yes, they have a foreign body—-the mesh—inside them, but it is not necessarily the mesh itself that will be the problem. Modern mesh construction is probably as good as we are going to get it; the base material allows for the ingrowth of fibrous material and scar tissue, which causes a fibrous scar and strengthens repair. Problems can occur over time with shrinkage or contraction of the fibrous scar, which can in turn lead to other problems. It is important that the mesh is inserted in a tension-free fashion so that there is a lesser possibility that it will cause injury. It is also important that, if it is used in a position where the bowel might come into contact with it, steps are taken to avoid that as much as possible.

Alexander Stewart Con Mid Scotland and Fife
link

We have heard that, in some situations, individuals had one mesh for a hernia put in but it had to be removed; they then had a second one put in and, since the second attempt, things have been better. They have not experienced the same complications since the first mesh was removed and the second one was implanted. Is there evidence, in your experience or that of others, of that happening when one mesh is removed and then replaced with a new one? Is it common or just an ad hoc situation that occurs with certain individuals?

10:00

Terry O’Kelly Scottish Government
link

I suspect that that is an ad hoc situation; I do not know the individual circumstances relating to the case that you cite. If, let us say, a mesh was put in and it was too tight—which can happen, as it is a technical exercise—the answer might be to remove that mesh and put in a tension-free mesh. It is possible that, if the mesh is inserted and held in place by sutures, a suture could entrap a nerve—it is very likely that one would not be able to see that at the time. Physically removing the foreign body from the vicinity of the nerve might alleviate the patient’s symptoms, but it might be necessary to remove the mesh to do that.

In the case that you described, it may be that the second mesh that was inserted was self-adhering or was inserted and held in place with tissue glue. There may be other such reasons. Why, in a car, does something not work, but, when you get it changed, it then works? It will be difficult to know precisely what the issue was in every circumstance, but such a situation is not common.

Jackson Carlaw Con The Convener · Eastwood
link

Minister, to go back to the Cumberlege report, I note that this committee was alert to the shortcomings surrounding the MRHA regimen, and I think that all parties in this Parliament endorsed the report’s recommendations. Did I understand you to say that you believe that the discussions that are taking place in relation to the report are constructive and are progressing to a positive outcome?

Maree Todd SNP Caithness, Sutherland and Ross
link

We in the Scottish Government are certainly working with the report and taking positive steps. There is still work to be done to ensure that patients’ voices are heard and listened to—that is why we proposed a patient safety commissioner in our programme for government; it was also a manifesto commitment. We consulted on that recently. The consultation has now closed, and we recently published a report that provided an analysis of the results. We are going to take that into account as we continue to work with patients and experts to develop the commissioner role. We are keen to do that in Scotland, and we are keen to deliver what patients are asking for on that front.

With regard to UK-wide discussions with the MHRA, there has been slow progress—as has often been the case over the past couple of years—which is understandable, given the situation that we are in. Nevertheless, we are pretty keen to pick that up as a priority and to make UK-wide progress on these issues.

Jackson Carlaw Con The Convener · Eastwood
link

MHRA regulation is reserved, but I think that there was a very strong feeling across all parties in this Parliament that, wherever support could be given to efforts that the Scottish Government was making to progress issues around the regulation of these devices, it would be forthcoming. I am sure that all parties are still willing and able to offer whatever support the Government feels that it might need if it is struggling to make the progress that we all want to see.

Maree Todd SNP Caithness, Sutherland and Ross
link

I will bear that in mind, convener, and I will take up your offer if necessary.

Paul Sweeney Lab Glasgow
link

I thank the witnesses for their contributions so far, which have been very interesting. I have some questions around mesh removal procedures and protocols. We have had a number of written submissions from members of the public—patients—who have experienced adverse outcomes and complications. Martin O’Neill commented that his life is improving now that he has had the mesh removed. He said:

“I’m still mesh afflicted due to the device being left so long in my body that pain and damage is permanent. BUT I have hope. It’s out! There is at least a possibility of me doing something with life rather than taking pills that don’t allow basic functioning, coupled with pain that still doesn’t stop sleepless nights and an overwhelming sense of wanting to die than live in that horror of pain that mesh causes.”

In other cases, individuals were told by surgeons that the mesh was too enmeshed in their body to be removed without causing serious consequences such as the loss of their rectum or testicles. Individuals have resorted to private surgery to get the mesh removed, with some even travelling abroad to do so.

In another written submission, Carole Coutts described difficulties in getting her mesh removed on the NHS in Scotland. She said:

“My GP ... discussed my case with other GPs. She said none of them knew much about mesh.?She tried referring me to the Scottish Complex Mesh Surgical Service”—

which is a service for women who are considering specialist surgical mesh removal—

“and I also emailed them”

as a patient.

“They refused my referral as they only accept gynaecological referrals.”

In 2018, your predecessor as chief medical officer wrote to the health board medical doctors in Scotland on the use of mesh in sites other than the vagina. In that letter, she said:

“The management of patients with mesh-related complications must follow agreed pathways which should involve a multi-disciplinary team of clinicians with appropriate skills and experience.”

In the light of all that, can you talk us through the “agreed pathways” for non-gynaecological “mesh-related complications” that your predecessor referred to in 2018? Do you believe that those pathways are operating as they should?

Professor Sir Gregor Smith Scottish Government
link

When the stories and the terrible symptoms that some are suffering as a consequence of some types of surgery are recounted, as you have recounted them, it is always very difficult, and you cannot help but be moved by their experience.

Terry O’Kelly will be able to say a little bit about the detail of some of the pathways, but you are absolutely right to suggest that we have created an expectation in boards that they should be developing pathways that not only offer alternatives to mesh surgery for patients who would prefer to explore other options but allow people who might have complications necessitating further revision surgery to explore that in a place of a specialist nature.

Each health board has what are called exceptional referral protocols. What happens just now—and, indeed, what has happened for many years—is that, where particular specialist services that require a high degree of competency are not available in a local board area, local staff are able through the exceptional referral protocol to refer outside that board to places that can provide them, either in another area in Scotland or even beyond Scottish borders. That has traditionally been one of the ways of trying to deal with this issue. Many surgeons in Scotland have a high level of competency in addressing some of the issues that you have described, particularly at the more complex end of mesh removal, but I would like to see greater consistency across Scotland in developing more localised services to provide that type of care. Indeed, that is why my predecessor and I have written to health boards.

As I have said, Mr O’Kelly might be able to say a little bit more about progress in that respect. We have heard that, later this year, there will be more detailed discussions with the Scottish Association of NHS Medical Directors on the progress that has been made following the letter that was sent to them towards the end of 2021—in December, I think.

Terry O’Kelly Scottish Government
link

I just want to make a couple of points. First, it is not only for the clinician to recognise the need for a second opinion—it is actually the patient’s right. If they are not receiving information or opinions that they are satisfied with, they should be able to ask to see somebody for a second opinion themselves. As a practising surgeon, I think that there is a great deal of security in asking somebody else to review a case; it helps not only me but the patient, and it is something that we need to support.

Pathways are germane to each circumstance. Because the hernias and complications that have occurred are not that common, the mesh procedures will be bespoke. It is important that care is individualised so that it is very much centred on the particular patient.

It is also important that clinicians form networks. That is certainly the case in my own health board area. Networks need support—especially administratively. It is essential that any conversations that occur are recorded and discussed with patients and that the outcomes of all deliberations are entered into the electronic patient record that will go forward in perpetuity. A bit of work still needs to be done to ensure that such a process is embedded into the work of every health board in Scotland.

With regard to private healthcare, it is a real shame that there is still a perception that, if I pay for something, I will get it done better. State services are often provided by the same people. We need to be able to provide exemplary care within our national health service for all patients, and I think that we are all committed to doing that.

Jackson Carlaw Con The Convener · Eastwood
link

Mr Sweeney, do you want to come in? Mr O’Kelly has slightly anticipated the question that we might have asked.

Paul Sweeney Lab Glasgow
link

Thank you for that contribution. The point about there being such a small number of cases in the national scale of things requires us to reflect on how best to address it. The pathways perhaps need consideration of how we might establish learning curves so that defects can be addressed by a network of people who are robustly capable of doing it rather than it being a lottery.

Could the NHS consider establishing a protocol for investigating such cases so that it could understand, for example, why someone has gone for a private surgical solution, what the outcome was and what could have happened differently? Is there a way of addressing the concerns that are expressed in the patients’ submissions that we have received, such as by conducting a deeper analysis of what has gone wrong in their journey to identify whether there are opportunities for improvement?

Professor Sir Gregor Smith Scottish Government
link

Audit is an incredibly important part of learning in medicine or surgery. The ability to reflect on practice and to obtain evidence of how practice has affected people and the outcomes that they have experienced—whether those are positive or, as has happened on the occasions that we are considering, negative—relies on the availability of good data. Some of the issues that we have heard about today—such as the scan for safety approaches, where we are able to have much greater information about the types of devices or materials that are used in different types of surgery—help us to better understand, over time, and through that data, the outcomes that people are experiencing.

Where care transcends the division between the NHS and private facilities it sometimes becomes a little more difficult to obtain such data and to be able to use it in a way that allows proper understanding. However, the point that you make is still critical. We rely on using such data to be able to understand the outcomes that are associated with it. The new protocols that will come into play will allow us to do that an awful lot better in the future.

Paul Sweeney Lab Glasgow
link

Okay. Thank you very much. I want to follow up on an instance that was mentioned earlier. It is in one of the submissions from a patient. The national complex mesh removal surgical service in Scotland accepts only gynaecological referrals. Why cannot patients who wish to have other types of surgical mesh removed utilise that service? Why is it restricted in that way?

Professor Sir Gregor Smith Scottish Government
link

Mr O’Kelly might want to add more to what I am about to say. The service has been set up with surgeons whose focus of training has been the urogynaecological use of mesh. Because that is so specialised and highly specific it would not be appropriate for them to look at the use of mesh in other sites—it is very site specific.

Terry O’Kelly Scottish Government
link

The centre was set up specifically for the purpose of managing complications from the use of urogynaecological mesh. There is a multidisciplinary team that consists of urogynaecologists, a urologist and colorectal surgeons.

10:15

If it is not yet doing so, the group will, over time, take on the burden of dealing with rectopexy mesh, which is very specialised and crosses the boundary between urogynaecology and colorectal surgery, at the interface between the last part of the large bowel and gynaecological structures such as the vagina. That is certainly the way in which such management procedures will proceed in England.

The centre has not been constructed to deal with other forms of mesh surgery. The clinicians are certainly available to be consulted, but they are not taking referrals for non-pelvic gynaecological mesh surgery, as I have described. That is appropriate for that particular centre.

Jackson Carlaw Con The Convener · Eastwood
link

I want to touch on the final area to which you alluded in your opening statement, minister, which is the evidence that we received from and the subsequent oral testimony of Dr Spencer Netto from Shouldice hospital in Canada. David Torrance will lead our questions on that.

David Torrance SNP Kirkcaldy
link

Good morning. In his evidence, Dr Spencer Netto highlighted how successful Shouldice hospital had been with natural tissue repairs, which have resulted in a low recurrence of hernias. How do pre-operative preparation and post-operative care for hernia repair surgery in Scotland differ from the steps undertaken in that hospital?

Maree Todd SNP Caithness, Sutherland and Ross
link

It is probably worth going to Mr O’Kelly on that question. As I understand it, Shouldice has a very specialised unit and patients there are somewhat pre-selected. It is therefore not a population that would be reflective of the general population who seek surgery in Scotland. That aside, its results are impressive and we are very interested in the work that is being done over in Canada. However, as I understand it, if we were to compare the population who use the unit in Canada with that seeking hernia repair in Scotland, there might be significant differences, for example in terms of obesity or ambulation.

I will hand over to Mr O’Kelly, who will be able to give you a better explanation.

Terry O’Kelly Scottish Government
link

The results and outcomes at Shouldice are very impressive. However, it has said that the relative contraindications and risks with regard to successful surgery are smoking; obesity; diabetes and other pre-existing conditions; the quality of the underlying structures; and the size of the defect. We do not have a great deal of control over some of the aspects that Mr Torrance mentioned in his question, but the build-up to surgery—or prehabilitation, which I think he might be alluding to—could have a significant role in getting patients fitter for surgery by getting them to stop smoking, increase their exercise levels if they can, lose weight, reduce alcohol consumption and so on. All those things are beneficial for patients and we aim to promote them. If surgery is then conducted in a “get it right first time” manner, patients will be in good shape and will benefit not only from the surgery itself but from post-operative mobilisation and return to normal activities at an earlier stage. There are lessons to be learned from the experience of Shouldice and measures that we can apply to improve the lot of patients who are having surgery in this country.

David Torrance SNP Kirkcaldy
link

There are very strict criteria at Shouldice hospital, especially on patient weight loss. In fact, Dr Spencer Netto told the committee that some of its patients have to lose between 50 and 100 pounds before the hospital will even see them before going ahead with a natural repair. Could such criteria be brought into play here? Would it be acceptable to do so?

Terry O’Kelly Scottish Government
link

This is very difficult—are we going to deny patients access to surgery if we believe that they are overweight? I suspect that that would be a subject for parliamentary debate. The other issue is around what problem the hernia is causing. Is it a strangulated hernia? Do we need to engage in life-saving surgery? Is it preventing them from working? We also know that, when patients are a certain size, losing weight becomes almost impossible without some other medical intervention, particularly if they are diabetic.

These are theoretical issues that are profound and worthy of consideration, but you may also have an opinion on that, which might be better than mine.

Professor Sir Gregor Smith Scottish Government
link

You have raised a very interesting ethical dilemma and it is one that many clinicians would feel uncomfortable with. I feel uncomfortable even talking about it just now. The restriction of access to treatment because of personal criteria is something that many clinicians feel deeply uncomfortable with, particularly when a health need lies at the bottom of it.

However, if we turn this concept around a little bit and look at how we can work with patients on education in relation to the concept of risk, we can then begin to explore an area where there is mutual benefit. It is about trying to encapsulate the risk of certain personal characteristics for people before they enter all sorts of treatment where risk is increased because of those personal characteristics.

The term “prehabilitation” is becoming more familiar to us all: using education, we can work with patients so that they can prepare themselves for surgery in a way that helps to reduce that risk. That is part of the conversation that we spoke about earlier when we spoke about the benefits, risks and alternatives and what happens if we do nothing.

We know that there are many approaches that we can take with patients to discuss that and to work with them. The two most obvious things to talk about are being overweight and being a smoker. Weight loss before surgery is a good thing if you are overweight. It does not matter what type of surgery you are undergoing—if you are more obese, greater risks are associated with surgery and general anaesthesia as a consequence of that. We know that, with abdominal surgeries specifically, such as hernia repairs, being more obese is associated with slightly poorer outcomes. It is a similar case with smoking.

Knowing those characteristics, you can then describe risk in different terms to those individuals. You can begin to calibrate risk for them. They will have their own level of tolerance to risk and they can then make their own judgment and say, “If I go forward and have this treatment that I really want and need to have, these are the things that I can do and can take personal responsibility for to contribute to better outcomes.” However, I think that many people would feel very uncomfortable about methods of restricting access to surgery, particularly when people are experiencing a lot of discomfort.

David Torrance SNP Kirkcaldy
link

Are the skills in natural tissue hernia repair techniques being lost in Scotland in favour of teaching surgeons mesh repairs? Could more surgeons in Scotland be receiving training in natural tissue methods?

Maree Todd SNP Caithness, Sutherland and Ross
link

Mr O’Kelly will want to come in on this but, as I understand it, there is real interest in improving the expertise within Scotland in natural tissue repair and they are looking at centres that use those techniques in Europe—just because of the ease and practicalities of links with Europe versus links with North America.

I will let Mr O’Kelly tell you a little bit more about that.

Terry O’Kelly Scottish Government
link

The Shouldice submission said that mesh surgical training is seen as being easier to teach and that is why that aspect of training was germane to training in Scotland. That is a bit disingenuous. There has been an emphasis on mesh training and mesh surgery because of its proven efficacy as revealed in the Scottish Health Technologies Group report.

That said, we need to offer patients choice—that is very important—and there will be some for whom mesh is not appropriate. With each health board, it is critical that, when appropriate, patients have access to non-mesh surgery, which might be provided by their health board or by another health board somewhere else in Scotland.

I cannot tell you how many surgeons we would need to train, but I think that it would be more than one. One of the discussions that we will have when we meet the Scottish Association of Medical Directors will be about the provision of training, and access to training, for colleagues who wish to do it. In my health board, one of my colleagues is keen to take that forward. He has started to make contacts, and he will probably travel with one of the surgeons from NHS Lothian. However, it will not be sufficient for one person in my board to have the necessary training; we need at least two people. The situation will depend on demand.

It is important that individual surgeons will not be performing one procedure per year. There will need to be a sufficient volume for the process to be effective and efficient. Colleagues will need to buddy up—certainly at the start—to make sure that the numbers are correct and that they refresh their skills through practice. One of the successes of Shouldice is that the surgeons there perform 600 or 700 procedures per year. That is 15 to 20 procedures per week, taking into account leave and one thing and another. Doing the same thing every day enables you to become very proficient. That is something that we also need to—Inaudible.

David Torrance SNP Kirkcaldy
link

The example of Shouldice hospital demonstrates the success of a specialised hernia repair unit. Would it be possible to have such a centre in Scotland, taking into account the criteria that would need to be met in order to have such a success rate?

Maree Todd SNP Caithness, Sutherland and Ross
link

I understand why you ask that question. I know from debates that have taken place in my constituency that there is a real tension between accessing healthcare as close to home as possible and being able to access national expertise when that is required. I get many more expressions of concern from constituents who have to travel within the constituency to access care than I do from people who want to travel to benefit from specialist expertise.

In NHS Scotland, the way we tend to work is that it should be possible for people to access routine care as close to home as possible. There are lots of good reasons for that. From the point of view of not just the medical model of health but the biopsychosocial model of health, with routine procedures it is important that people are treated close to home, have support around them and are able to recover well within their family and their community.

However, with particularly challenging or complex procedures, we need to build in expertise. We will have to work in a networked way across Scotland to deliver that. We have said that there are challenges with volume. If people are to train in natural tissue repair, they will have to see enough people to maintain that training. We will certainly consider what is the best model for Scotland but, at the moment, I am not minded to reconstruct the unit in Canada here in Scotland.

I will hand over to Mr O’Kelly, who is keen to come in.

Jackson Carlaw Con The Convener · Eastwood
link

We are quite short of time, and we still have a couple of questions to come.

Terry O’Kelly Scottish Government
link

With the creation of the national network of treatment and diagnostic centres, there will be some migration of patients in their locale to those facilities. That will provide an opportunity to concentrate colleagues who have particular expertise and interest in such fields. It may be that, as their careers develop, they will choose to have a more scheduled workload, instead of providing unscheduled care in the way they do at the moment. If they did more hernia lists, that would increase the numbers and would result in a move towards more of a Shouldice-type model. However, for most of our colleagues, I am not sure that doing one thing all the time is a very attractive way of spending their professional life.

Jackson Carlaw Con The Convener · Eastwood
link

Thank you. We are very short of time now, although we are grateful for the time that you have given us. I invite Alexander Stewart and Paul Sweeney to ask their supplementary questions, and then the minister can round up the discussion with any final comments in response.

10:30

Alexander Stewart Con Mid Scotland and Fife
link

Minister, you touched on the need to try to create facilities to support individuals. Canada gives us a good example of what can be achieved. I appreciate that you want to ensure that medical support is given to individuals at the closest point, but some degree of specialisation may still be required, perhaps by creating a unit or expertise in the field for clinicians. That should be considered, as it could help to iron out some of the difficulties that we have seen. It would be good to get your views on that.

Paul Sweeney Lab Glasgow
link

I want to build on the point about the Scottish complex mesh surgical service being the opportunity to evolve the model. Given that there is such a small volume of defects in the national population base, combined with Scotland’s relatively small geography and population base, the idea of a concentration of skills to deal with and rectify complex defects could provide a way to build the service to include some of the examples that Dr Spencer Netto has called for as key takeaways. Building that national centre would not be to say that everyone has to get a surgical mesh repair for a hernia in a national centre in Glasgow—for example, if they live in Lerwick. However, if there are complex or high-risk cases, that might be the most appropriate solution. Do you agree that we should look at that?

Maree Todd SNP Caithness, Sutherland and Ross
link

Certainly. The Shouldice hospital deals with more routine operations and at quite high volume. In order to give people options in highly skilled and trained surgeons who are using those techniques, that is something that we need to explore on a national basis, although we can also build up local expertise.

I agree that there needs to be a national multidisciplinary team to look at those particularly complex cases. Clinicians from all over the country need to be able to access that expertise. It is difficult to understand how challenging it can be to communicate across boundaries in the NHS. That is a theme that comes up time and again. We are very keen to bust those boundaries to ensure that clinicians can access the expertise that they require for their patients, wherever they live in the country.

We are also mindful of developing systems that mean that patients, wherever they live, can access the right level of expertise. People in Lerwick are probably more comfortable with travelling than people on the mainland because they travel all the time. Patient choice needs to be part of it. We need to make shared decisions with patients about what is the best option for them.

Professor Sir Gregor Smith Scottish Government
link

One of the concepts that were explored in the extant clinical strategy for the country is the tension between competence for any given procedure or approach to care, and the volume of patients likely to be seen. There is a recognition that sometimes we need to look at ways where, nationally, we can provide care for the low-volume procedures. All clinicians would sign up to that. However, there are different ways to achieve that.

Mr O’Kelly has spoken about the informal and formal networks that develop around care that can provide that highly specialised approach when it is required. That underpins much of our clinical strategy. Occasionally, there is a need to develop that further to create centres of excellence where there is a much more formalised structure and approach. The difficulty is gauging the best method to provide support to people when they need it.

Terry O’Kelly Scottish Government
link

That point is well made. An issue that Sir Gregor might want to take to the medical directors for discussion is how we can ensure that the best opinions and skills are applied when they are required, on all occasions. That means engagement between the board networks. The question is how we improve liaison and allow that cross-fertilisation of ideas.

Jackson Carlaw Con The Convener · Eastwood
link

I do not know whether you saw any of our evidence session with the Shouldice hospital. I understand that there are questions of geography but, in principle, Dr Spencer Netto said that he would be very happy to facilitate any access to the expertise that they have developed with their clinicians to benefit Scotland’s NHS, were that thought to be useful. They would be happy to explore that further if the Scottish Government wanted to pursue that.

I thank all three witnesses for giving evidence this morning.

10:35 Meeting suspended.

10:39 On resuming—

Jackson Carlaw Con The Convener · Eastwood
link

I welcome everyone back. For confirmation, are members content to consider the evidence that we heard on the previous petition at a future meeting?

Members indicated agreement.

  1. 09:30 Continued Petitions Petitions · 58
  2. 10:30 Continued Petitions Petitions · 57
  3. 11:30 Continued Petitions Petitions · 9
  4. 11:30 Continued Petitions Petitions · 3
  5. 11:30 Continued Petitions Petitions · 4

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.